US Morning Briefing 29.03.2007 - 500 Beiträge pro Seite

[GoofMan]

Guten Morgen,

hier wieder die US Tagsmover für den 29.03.2007.

Disclaimer wie immer: Das ist für erfahrende Trader die richtig handeln wollen und keine Leute, die "sichere 10000% Chancen" im Board suchen


Here we go:

EMIS Emisphere Tech says study shows orally-delivered GLP-1 is able to stimulate insulin release

CLSC Cobalis Locks Database for Pivotal Twin Phase III Trials of PreHistin(TM) in Seasonal Allergic Rhinitis

ERIC Ericsson wins WCDMA/HSPA contract with S?minn in Iceland

UTIWUTi Worldwide 4th-quarter net doubles, revenue up 31%

MOV Movado Group, Inc. Posts Record Net Sales and Net Income in Fiscal 2007

KMX CarMax Reports Record Fourth Quarter and Fiscal Year 2007 Results

CHU China Unicom 2006 Profits Down 24 Pct

CHINA CDC Corporation Reports Record Revenues of (U.S.)$89 Million and Adjusted Net Income of $8.8 Million for Fourth Quarter of 2006, an Increase of 43% and 38%, Respectively, Over the Prior Year Period

[GoofMan]

DNDN Halted, news pending. FDA Entscheidung soll heute kommen. Das war der Play aus einem der letzten Morning Briefings.

[GoofMan]

TGEN Targeted Genetics Reports Fourth Quarter and Year-End 2006 Financial Results, Profitable quarter after loss
For the quarter ended December 31, 2006, the Company reported net income of $808,000, or $0.08 per common share, compared to a net loss of $3.6 million, or a loss of $0.41 per common share, for the fourth quarter of 2005. For the year ended December 31, 2006, the Company reported a net loss of $34.0 million, or $3.47 per common share, compared to a loss of $19.2 million, or $2.24 per commonshare, for the same period in 2005.

EGHT 8x8, Inc. to Provide Packet8 Virtual Office VoIP Phone Services to U.S. Army Installation
The agreement, which represents 8x8's first U.S. government contract, calls for the installation of 15 Packet8 Virtual Office Unlimited Extensions

[GoofMan]

PTR BEIJING, March 29 (Reuters) - A 2.2 billion-barrel reserve estimate reportedly attached to a major PetroChina oilfield is an

oil-in-place figure more than one year out of date, and is likely to be revised by July, industry officials said on Thursday. "That

figure was a very preliminary one out in 2005. Before we complete drilling all the required amount of wells, we will not know how

big the field is," said one exploration official. He said the company would firm up the figure by July.

NEOL WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, INC. (Nasdaq:NEOL - News) today announced that it has met with officials of the

Office of Oncology of the FDA to discuss the Company's clinical trial data from its Phase 3 PRECISE trial for use of Cintredekin.

The Company is disappointed with the Office of Oncology's position, which, if implemented, would significantly delay the

introduction of this therapy to GBM patients. Besudotox in the treatment of recurrent glioblastoma multiforme (GBM).